Wenliang Ma
Overview
Explore the profile of Wenliang Ma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ma W, Chen Y, Chen G, Yang L, Lu Y, Dong X, et al.
Cell Commun Signal
. 2025 Mar;
23(1):122.
PMID: 40050998
Background: TFE3 rearranged renal cell carcinoma (TFE3 rRCC), classified as a distinct entity of RCCs, exhibits aggressive biological behavior and possesses unique metabolic characteristics. In the present study, TFE3 rRCC...
2.
Zhao Y, Yang Y, Zhang B, Cui H, Liu L, Wang R, et al.
MedComm (2020)
. 2025 Feb;
6(3):e70117.
PMID: 40008378
Intratumoral brachytherapy enables higher dose treatment and reduces damage to adjacent tissues. We first validated the feasibility and safety of endoscopic ultrasound (EUS)-guided Yttrium-90 (Y) microspheres implantation in a porcine...
3.
Li X, Wu M, Chen G, Ma W, Chen Y, Ding Y, et al.
Mol Carcinog
. 2025 Feb;
PMID: 39991877
The initiation and progression of clear cell renal cell carcinoma (ccRCC) are closely linked to significant metabolic alterations. Specifically, lipid metabolism alterations and their association with the high invasiveness in...
4.
Wu M, Chen G, Li X, Ma W, Chen Y, Gong Y, et al.
Cell Signal
. 2025 Jan;
127:111622.
PMID: 39875047
Autophagy-mediated anoikis resistance plays a critical role in the initiation of tumor metastasis. Therefore, we investigated the role and mechanism of anoikis resistance mediated by free fatty acids (FFAs) derived...
5.
Yang H, Dong X, Pan X, Ma W, Pan J, Guo H, et al.
Front Oncol
. 2023 Nov;
13:1252282.
PMID: 37936602
-rearranged renal cell carcinoma (RCC) is a rare subtype of renal tumor that primarily affects young women and is characterized by early metastasis and a poor prognosis. This case study...
6.
Chen Y, Lu Y, Yang L, Ma W, Dong Y, Zhou S, et al.
J Exp Clin Cancer Res
. 2023 Sep;
42(1):252.
PMID: 37770905
Background: NONO-TFE3 rearranged renal cell carcinoma (NONO-TFE3 rRCC) is one of a subtype of TFE3 rRCCs with high malignancy and poor prognosis. Compared with clear cell RCC, NONO-TFE3 rRCC shows...
7.
Lu Y, Zhu Y, Ma W, Liu N, Dong X, Shi Q, et al.
Sci Rep
. 2023 Apr;
13(1):6141.
PMID: 37061606
Based on the epidemiological characteristics of susceptibility and age selectivity for women in Xp11.2 translocation renal cell carcinoma (Xp11.2 tRCC), we inferred that estrogen was to be blamed. Rad54 like...
8.
Wang D, Wang J, Zheng X, Diao S, Li W, Ma W
Front Med (Lausanne)
. 2022 Dec;
9:1017411.
PMID: 36530881
Introduction: Sepsis is a common clinical syndrome and nearly 20% of all deaths are related to sepsis. As an important part of the body, bone homeostasis disorders are closely related...
9.
Ma W, Li X, Yang L, Pan J, Chen Y, Lu Y, et al.
J Transl Med
. 2022 Dec;
20(1):554.
PMID: 36463181
Background: Clear cell renal cell carcinoma (ccRCC), the most common urological malignancy, has an unfavorable prognosis and an unknown mechanism of progression. Through survival analyses screening of The Cancer Genome...
10.
Yang L, Yin H, Chen Y, Pan C, Hang H, Lu Y, et al.
Exp Hematol Oncol
. 2022 Nov;
11(1):87.
PMID: 36348434
Background: Pseudogenes play an essential role in tumor occurrence and progression. However, the functions and mechanisms of pseudogenes in clear cell renal cell carcinoma (ccRCC) remain largely elusive. Methods: We...